Anteris Technologies (ASX:AVR) Cash And Cash Equivalents : A$30.83 Mil (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Anteris Technologies Cash And Cash Equivalents?

Anteris Technologies's quarterly cash and cash equivalents increased from Dec. 2022 (A$13.81 Mil) to Jun. 2023 (A$20.26 Mil) and increased from Jun. 2023 (A$20.26 Mil) to Dec. 2023 (A$30.83 Mil).

Anteris Technologies's annual cash and cash equivalents declined from Dec. 2021 (A$21.30 Mil) to Dec. 2022 (A$13.81 Mil) but then increased from Dec. 2022 (A$13.81 Mil) to Dec. 2023 (A$30.83 Mil).

Anteris Technologies Cash And Cash Equivalents Historical Data

The historical data trend for Anteris Technologies's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anteris Technologies Cash And Cash Equivalents Chart

Anteris Technologies Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

Get a 7-Day Free Trial

8.97

4.35

21.30

13.81

30.83

Anteris Technologies Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial															21.30	33.10	13.81	20.26	30.83

Anteris Technologies Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Anteris Technologies (ASX:AVR) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Anteris Technologies Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Anteris Technologies's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Anteris Technologies (ASX:AVR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Anteris Technologies Ltd (ASX:AVR) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

AMEUF:USA

Address

Level 3, 9 Sherwood Road, Suite 302, Toowong Tower, Toowong, QLD, AUS, 4066

Website

https://www.anteristech.com

Anteris Technologies Ltd is a structural heart company engaged in delivering clinically superior solutions that help healthcare professionals create life-changing outcomes for patients. The group's solutions include Anteris' DurAVR transcatheter heart valve for younger patients who need a heart valve that will last their lifetime, as well as DurAVR with its biomimetic design that replicates the normal blood flow of a healthy human aortic valve. The company derives key revenue from Australia and the U.S.

Anteris Technologies (ASX:AVR) Headlines

No Headlines